Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel‐group clinical trial sub‐study

This randomised controlled trial demonstrated that the use of a tubeless AID system improved psychosocial measures to a greater extent than SAP therapy. These results contribute to the growing body of evidence demonstrating that AID may improve quality of life and alleviate some of the burden associated with diabetes self-management in adults with T1D.

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2026-01-08
DOI
https://doi.org/10.1111/dom.70416
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel‐group clinical trial sub‐study

MARK KIPNES, IRL HIRSCH, Rayhan A. Lal, Sue Brown et al.
Diabetes Obesity and Metabolism
Diabetes Management and Research
article

Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel‐group clinical trial sub‐study

MARK KIPNES, IRL HIRSCH, Rayhan A. Lal, Sue Brown, Grazia Aleppo, L. M. Laffel, Jean‐Pierre Riveline, Viral N. Shah, Kristin Castorino, Ruth S. Weinstock, Eric Renard, Charles Thivolet, Alfred Penfornis
article en

Abstract

This randomised controlled trial demonstrated that the use of a tubeless AID system improved psychosocial measures to a greater extent than SAP therapy. These results contribute to the growing body of evidence demonstrating that AID may improve quality of life and alleviate some of the burden associated with diabetes self-management in adults with T1D.

Diabetes Obesity and MetabolismVol. 28(3)
Northwestern University (US), Joslin Diabetes Center (US), Centre National de la Recherche Scientifique (FR), Harvard University (US), Inserm (FR), Université de Montpellier (FR), University of Washington (US), SUNY Upstate Medical University (US), Université Paris Cité (FR), Diabetes Australia (AU), Institut Necker Enfants Malades (FR), Centre Hospitalier Universitaire de Montpellier (FR), Assistance Publique – Hôpitaux de Paris (FR), Sansum Diabetes Research Institute (US), Atlanta Diabetes Associates (US), Centre Hospitalier Sud Francilien (FR), Hôpital Lariboisière (FR), Diabetes & Glandular Disease Clinic (US), Institute for Neurosciences of Montpellier (FR), University of Virginia (US), Indiana University – Purdue University Indianapolis (US), Stanford University (US)
University of Pennsylvania, Northwestern University, Syracuse University, State University of New York, University of Washington, Joslin Diabetes Center, Insulet Corporation, Feinberg School of Medicine, State University of New York Upstate Medical University
Openalex Percentile: Top 94%
Diabetes Management and Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.